During the past 3 years, the average Free Cash Flow per Share Growth Rate was -10.10% per year.
During the past 5 years, the average Free Cash Flow per Share Growth Rate was 15.20% per year.
During the past 10 years, the average Free Cash Flow per Share Growth Rate was 58.30% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.
During the past 13 years, the highest 3-Year average Free Cash Flow per Share Growth Rate of Emmaus Life Sciences was 86.30% per year. The lowest was -657.00% per year. And the median was 16.60% per year.
Competitive Comparison of Emmaus Life Sciences's 3-Year FCF Growth Rate
For the Biotechnology subindustry, Emmaus Life Sciences's 3-Year FCF Growth Rate, along with its competitors' market caps and 3-Year FCF Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Emmaus Life Sciences's 3-Year FCF Growth Rate Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Emmaus Life Sciences's 3-Year FCF Growth Rate distribution charts can be found below:
* The bar in red indicates where Emmaus Life Sciences's 3-Year FCF Growth Rate falls into.
Emmaus Life Sciences 3-Year FCF Growth Rate Calculation
This is the 3-year average growth rate of Free Cash Flow per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.
Emmaus Life Sciences (OTCPK:EMMA) 3-Year FCF Growth Rate Explanation
Free Cash Flow per Share is the amount of Free Cash Flow per outstanding share of the company's stock. Free Cash Flow is considered one of the most important parameters to measure a company's earnings power by value investors because it is not subject to estimates of Depreciation, Depletion and Amortization (DDA). However, when we look at the Free Cash Flow, we should look from a long term perspective, because any year's Free Cash Flow can be drastically affected by the spending on Property, Plant, & Equipment (PPE) of the business in that year. Over the long term, Free Cash Flow should give pretty good picture on the real earnings power of the company. It's used in the calculation of Forward Rate of Return (Yacktman) %.
Emmaus Life Sciences 3-Year FCF Growth Rate Related Terms
Thank you for viewing the detailed overview of Emmaus Life Sciences's 3-Year FCF Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.
Emmaus Life Sciences Inc is a biopharmaceutical company engaged in the discovery, development, and commercialization of new treatments and therapies predominantly for rare and orphan diseases. The company's commercial product is Endari, an oral pharmaceutical grade L-glutamine treatment indicated to reduce acute complications of sickle cell disease in adult and pediatric patients five years of age and older. Its products in the pipeline include Diverticulosis and Cell Sheet Engineering.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
EMMA has been successfully added to your